Urgent surgery compared to fibrinolytic therapy for the treatment of left-sided mechanical valve thrombosis (SAFE-PVT): a randomized controlled trial

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Ganesan Karthikeyan

All India Institute of Medical Sciences AIIMS New Delhi, New Delhi (India)

7 More presentations in this session

Presentation thumbnail

Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock - 12 months results of the ECLS-SHOCK trial

Professor S. Desch (Leipzig, DE)

Presentation thumbnail

Impact of baseline surgical risk on the treatment effect of PCI and CABG in ischemic left ventricular systolic dysfunction: results of the REVIVED-BCIS2 and STICH randomized controlled trials

Doctor G. Marquis-Gravel (Montreal, CA)

Presentation thumbnail

Empagliflozin for prevention of acute kidney injury in patients with type 2 diabetes mellitus undergoing extracorporeal on-pump CABG: The POST-CABGDM trial

Doctor F. Pitta (Sao Paulo, BR)

Presentation thumbnail

Comparative Effectiveness of Percutaneous and Surgical Revascularisation in Ischaemic Left Ventricular Systolic Dysfunction: Combined Patient-Level Analysis of the REVIVED-BCIS2 and STICH Trials

Doctor M. Ryan (London, GB)

Presentation thumbnail

Temporary mechanical circulatory support in infarct-related cardiogenic shock - An individual patient data meta-analysis of all randomized trials with 6-month follow-up

Professor H. Thiele (Leipzig, DE)

Access the full session

Session thumbnail

Smaller trials and trial updates on shock, surgery, and other interventions

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

Recombinant tissue plasminogen activator as a modifier of treatment effect in prosthetic valve thrombosis: systematic review and meta-regression

Congress Session

Late-breaking science on valve disease and hypertrophic cardiomyopathy

Congress Session

Smaller trials and trial updates on shock, surgery, and other interventions

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources